SNDX vs SOFI · rev $137.7M vs P/E 39, rev $283.1M
Syndax Pharmaceuticals Inc (SNDX) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
SNDX currently screens at market cap $774.4M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the SNDX and SOFI stock pages for the full models.
Not investment advice.